Galt Pharmaceuticals Franchise Disclosure Document (FDD)
The Galt Pharmaceuticals Franchise Disclosure Document is the most comprehensive public record of how the company operates — financial statements, fee schedules, litigation history, and system-wide unit counts, disclosed under federal mandate. The 2026 filing is available here as a complete PDF.
Available Documents
Galt Pharmaceuticals 2026 Franchise Disclosure Document (FDD)
Issued June 2026 · 186-page PDF
$99.00
- Initial investment (Item 7):
- $122,350 – $348,700 (p. 20)
Note: Purchased documents are delivered as instant PDF downloads. The price covers acquisition, storage, organization, and digital delivery of the document.